1-9 of 9
Anne Beaven
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of a Multicenter Pilot Study Evaluating Brentuximab Vedotin with Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the Treatment of Aggressive Adult T-Cell Leukemia/Lymphoma

Free
Christopher Dittus, Matthew Weinstock, Jeffrey A. Barnes, Jose Sandoval-Sus, Natalie S. Grover, Anne Beaven, Xianming Tan, Areej El-Jawahri, Shayna R Sarosiek, John Mark Sloan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1692.
https://doi.org/10.1182/blood-2023-173822
Published: 2023
Journal Articles

High Risk Cytogenetic and Immunohistochemistry Findings in Monomorphic Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplant - a Single Center Experience

Free
Timothy J Voorhees, MD, Natalie S Grover, MD, Jonathan Galeotti, MD MS, Nathan D Montgomery, MD, Dominic T. Moore, MPH, MS, Anne Beaven, MD, Christopher Dittus, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 2915.
https://doi.org/10.1182/blood-2019-126228
Published: 2019
Journal Articles

Retrospective Cohort Study Analyzing the Safety and Efficacy of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Free
Timothy J Voorhees, MD, Natalie S Grover, MD, Anne Beaven, MD, Steven I Park, MD, J. Kaitlin Morrison, PhD, Catherine Joyce Arago Cheng, BS, Spencer Laing, BA, Gianpietro Dotti, MD, Barbara Savoldo, MD PhD, Jonathan S Serody, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3233.
https://doi.org/10.1182/blood-2019-122846
Published: 2019
Journal Articles

Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin

Free
Natalie S Grover, MD, Steven I Park, MD, Anastasia Ivanova, PhD, Paul Eldridge, PhD, Kathryn McKay, MS, MT (ASCP), Catherine Joyce Arago Cheng, BS, Spencer Laing, BA, Deborah Covington, RN, BSN, John West, PhD, S. Elizabeth Sharf, RN, BSN, J. Kaitlin Morrison, PhD, Shaw Scott, Erin Crecelius, MA, Desirae Shelley, Maurice Alexander, PharmD, Faith Brianne Buchanan, PA, Emily Herrick Kassam, NP, Megan McElfresh, PA-C, Alicia R Pinto, NP, Angela Denise Spruill, ANP, Ashley Zanter, ANP, Kimberly Wehner, FNP, Christopher Dittus, DO, Thomas C. Shea, MD, Gianpietro Dotti, MD, Jonathan S Serody, MD, Anne Beaven, MD, Barbara Savoldo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 681.
https://doi.org/10.1182/blood-2018-99-113534
Published: 2018
Journal Articles

Successful Treatment of Mature T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: The Largest Multicenter Retrospective Analysis

Free
Neha Mehta-Shah, MD, Stephanie Teja, Yu Tao, MD, Amanda F. Cashen, MD, Anne Beaven, MD, Onder Alpdogan, MD, Pierluigi Porcu, MD, Mackenzie Wiggin, Kevin W Song, MD, Musa Alzahrani, Parastoo B. Dahi, MD, Alison J. Moskowitz, MD, Steven M. Horwitz, MD, Eric D. Jacobsen, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4597.
https://doi.org/10.1182/blood.V130.Suppl_1.4597.4597
Published: 2017
Journal Articles

A Phase I-II Study of the Combination of Bendamustine and Pomalidomide with Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma.

Free
Cristina Gasparetto, MD, Michael Green, MD, Anandgopal Srinivasan, MDcal Student, Yubin Kang, MD, David A. Rizzieri, MD, Carlos Decastro, MD, Louis F. Diehl, MD, Anne Beaven, MD, Zighuo Li, PhD, Arati V. Rao, MD, Anderson Garrett, Sascha Tuchman, MD, Gwynn D. Long, MD
Journal: Blood
Blood (2015) 126 (23): 1857.
https://doi.org/10.1182/blood.V126.23.1857.1857
Published: 2015
Journal Articles

A Phase 1b Clinical Trial of Dacetuzumab in Combination with Rituximab and Gemcitabine: Multiple Responses Observed in Patients with Relapsed Diffuse Large B-Cell Lymphoma.

Free
Andres Forero-Torres, MD, Nancy L Bartlett, MD, Sunita D Nasta, MD, Donald Northfelt, MD, Anne Beaven, MD, Han Myint, FRCP, FRCPath, Nancy C Whiting, PharmD, BCOP, Jonathan G Drachman, MD, Craig H Moskowitz, MD
Journal: Blood
Blood (2009) 114 (22): 586.
https://doi.org/10.1182/blood.V114.22.586.586
Published: 2009
Journal Articles

Early Pre/Post Fluoro-Deoxyglucose Positive Emission Tomography (PET) Does Not Predict Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation in Hodgkins Disease and Non-Hodgkins Lymphoma.

Free
Jeanne Palmer, MD, Timothy Goggins, MD, Gloria Broadwater, Nelson J. Chao, MD, John Chute, MD, R. E. Coleman, MD, Keith M Sullivan, MD, Gwynn Long, MD, Cristina Gasparetto, MD, Anne Beaven, MD, David Rizzieri, MD
Journal: Blood
Blood (2008) 112 (11): 2180.
https://doi.org/10.1182/blood.V112.11.2180.2180
Published: 2008
Journal Articles

A Phase I Study of Bortezomib (Velcade ® ) Plus 90 yttrium Labeled Ibritumomab Tiuxetan (Zevalin ® ) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (NHL)

Free
Anne Beaven, MD, Thomas C. Shea, MD, Dominic T Moore, PhD, Tatyana Feldman, MD, Anastasia Ivanova, PhD, Madlyn Ferraro, RN, OCN, CCRC, Peggy Ford, RN, Judy Smith, RN, Andre Goy, MD
Journal: Blood
Blood (2008) 112 (11): 4944.
https://doi.org/10.1182/blood.V112.11.4944.4944
Published: 2008